Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 1, 2024
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
[ Wed, May 01st 2024
] - WOPRAI
Tue, April 30, 2024
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
[ Tue, Apr 30th 2024
] - WOPRAI
Sean Dodge Maintained (CDMO) at Buy with Increased Target to $8 on, Apr 30th, 2024
Sean Dodge of RBC Capital, Maintained "Avid Bioservices, Inc." (CDMO) at Buy with Increased Target from $7 to $8 on, Apr 30th, 2024.
Sean has made no other calls on CDMO in the last 4 months.
There is 1 other peer that has a rating on CDMO. Out of the 1 peers that are also analyzing CDMO, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- Jacob Johnson of "Stephens & Co." Maintained at Buy with Decreased Target to $12 on, Monday, March 11th, 2024
